SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001213900-21-065511
Filing Date
2021-12-16
Accepted
2021-12-15 17:35:18
Documents
11

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT prer14a_helixacq.htm PRER14A 15798727
2 GRAPHIC tchart_001.jpg GRAPHIC 338045
3 GRAPHIC tchart_002.jpg GRAPHIC 396429
4 GRAPHIC tchart_003.jpg GRAPHIC 324712
5 GRAPHIC timage_005.jpg GRAPHIC 196165
6 GRAPHIC timage_004.jpg GRAPHIC 193389
7 GRAPHIC timage_006.jpg GRAPHIC 546851
8 GRAPHIC timage_007.jpg GRAPHIC 236580
9 GRAPHIC tchart_008.jpg GRAPHIC 464904
10 GRAPHIC tsvbleer_logo.jpg GRAPHIC 55371
11 GRAPHIC tsvbleer_footer.jpg GRAPHIC 111768
  Complete submission text file 0001213900-21-065511.txt   19746291
Mailing Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116
Business Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116 857 702 0370
Helix Acquisition Corp (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-39630 | Film No.: 211495214
SIC: 2834 Pharmaceutical Preparations